Hatib, Fauzan S.

HRN: 23-52-04  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/11/2023
AMPICILLIN 500MG (VIAL)
08/11/2023
08/18/2023
IV
450mg
Q6hours
Pneumonia, Low Risk
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: